SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Joe Reich who wrote (21278)4/23/1999 5:30:00 PM
From: VLAD  Read Replies (1) | Respond to of 23519
 
Joe,

If Astra didn't decide to merge with Zeneca we would have had a partnership deal signed last year. Seems to me like timing has always not been kind to us. I believe that after the jerk at Zeneca sees how well MUSE does in Germany in May, Vivus will have its deal.



To: Joe Reich who wrote (21278)4/23/1999 6:43:00 PM
From: RT  Read Replies (2) | Respond to of 23519
 
<<I'm already 46 years old - will I see that before I need either Muse or the incontinence product?>>

Joe,

The stress of holding this stock can render you impotent in months. Just ask VLAD.

RT


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News